Objective: To construct and validate a prognostic model for osteosarcoma prognostication and therapeutic potential of PANoptosisrelated genes. Study Design: Observational study. Place and Duration of the Study:Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China, from August 2021 to January 2024. Methodology: Transcriptomic data from the GEO and TARGET databases were utilised to construct and validate a prognostic model for osteosarcoma. The analysis involved the use of the LASSO Cox-regression method with theGlmnet R package to identify key PANoptosis-related genes. Di erential gene expression analysis was conducted using the Limma R package, and model validation was performed using Kaplan-Meier survival analysis and time-dependent ROC curves. Results: This model, derived from ve key PANoptosis-related genes, demonstrated signi cant predictive capability for patient survival across training and validation cohorts. Further analysis con rmed the model's e ectiveness and identi ed metastasis stage and risk scores as the robust independent prognostic indicators. Conclusion: The prognostic model o ers a novel tool for osteosarcoma prognostication and underscores the therapeutic potential of targeting PANoptosis-related pathways.